XDx Selects Franek Technologies To Protect $900,000 In Instrumentation Enabling Revolutionary Post-Cardiac Transplant Rejection Monitoring

TUSTIN, CA -- (MARKET WIRE) -- October 30, 2006 -- Franek Technologies, Inc., the leader in certified Category III-3 Laboratory Battery Backup Power Protection Systems (LPS/UPS), has been selected to protect XDx’s $900,000 investment in Applied Biosystems 7900 Sequence Detection Systems used in the company’s post-cardiac transplant rejection monitoring research. Based on past experience with brownouts at its research facilities, XDx proactively sought the higher-level power protection offered by Franek Technologies to protect not only its substantial investment in instrumentation, but most importantly, the irreplaceable patient samples that are paramount to testing for acute cellular rejection in post-cardiac transplant patients.

MORE ON THIS TOPIC